IP Library Assignment 068550/0744
Patent Assignment
Reel/Frame 068550/0744

Assignment of Assignor's Interest

Recorded: 2024-08-12 Pages: 3
Assignor
NUCHEM THERAPEUTICS INC.
Executed: 2021-05-17
Assignee
VIGIL NEUROSCIENCE, INC.
100 FORGE ROAD, SUITE 700, WATERTOWN, MASSACHUSETTS, 02472
Covered Property (1)
Heterocyclic Compounds as Triggering Receptor Expressed on Myeloid Cells 2 Agonists and Methods of Use
Application: 18/472,147 →
Publication: US 2024/0182477
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 12, 2024
From: HOUZE, JONATHAN B.
To: VIGIL NEUROSCIENCE, INC.
Reel/Frame 068247/0283 →
Assignment of Assignor's Interest Aug 12, 2024
From: BOS, MAXENCE; MANCUSO, JOHN; FRANZONI, IVAN
To: NUCHEM THERAPEUTICS INC.
Reel/Frame 068247/0675 →
Assignment of Assignor's Interest Aug 12, 2024
From: CZABANIUK, LARA C.; HOPPER, TIMOTHY; PANTELEEV, JANE; RESCOURIO, GWENAELLA
To: AMGEN INC.
Reel/Frame 068550/0673 →